Zentalis Pharmaceuticals

-$2.00 (-2.67%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.

About ZNTL

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations.

CEO
Anthony Y. Sun
Employees
124
Headquarters
New York, New York
Founded
2014

ZNTL Key Statistics

Market Cap
3.28B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
237.55K
High Today
$75.30
Low Today
$71.85
Open Price
$74.28
Volume
193.17K
52 Week High
$81.40
52 Week Low
$34.48

ZNTL Earnings

-$2.88
-$1.92
-$0.96
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure